ABCD2 p.Asp207His
Predicted by SNAP2: | A: D (75%), C: D (75%), E: D (59%), F: D (85%), G: D (85%), H: D (85%), I: D (85%), K: D (91%), L: D (85%), M: D (85%), N: D (80%), P: D (91%), Q: D (75%), R: D (85%), S: D (75%), T: D (80%), V: D (80%), W: D (91%), Y: D (85%), |
Predicted by PROVEAN: | A: D, C: D, E: D, F: D, G: D, H: D, I: D, K: D, L: D, M: D, N: D, P: D, Q: D, R: D, S: D, T: D, V: D, W: D, Y: D, |
[switch to compact view]
Comments [show]
None has been submitted yet.
[hide] Substrate specificity overlap and interaction betw... J Biol Chem. 2011 Mar 11;286(10):8075-84. Epub 2011 Jan 5. Genin EC, Geillon F, Gondcaille C, Athias A, Gambert P, Trompier D, Savary S
Substrate specificity overlap and interaction between adrenoleukodystrophy protein (ALDP/ABCD1) and adrenoleukodystrophy-related protein (ALDRP/ABCD2).
J Biol Chem. 2011 Mar 11;286(10):8075-84. Epub 2011 Jan 5., [PMID:21209459]
Abstract [show]
X-linked adrenoleukodystrophy (X-ALD) is a neurodegenerative disorder caused by mutations in the ABCD1 gene, which encodes a peroxisomal member of the ATP-binding cassette (ABC) transporter subfamily D called ALDP. ALDP is supposed to function as a homodimer allowing the entry of CoA-esters of very-long chain fatty acids (VLCFA) into the peroxisome, the unique site of their beta-oxidation. ALDP deficiency can be corrected by overexpression of ALDRP, its closest homolog. However, the exact nature of the substrates transported by ALDRP and its relationships with ALDP still remain unclear. To gain insight into the function of ALDRP, we used cell models allowing the induction in a dose-dependent manner of a wild type or a mutated non-functional ALDRP-EGFP fusion protein. We explored the consequences of the changes of ALDRP expression levels on the fatty acid content (saturated, monounsaturated, and polyunsaturated fatty acids) in phospholipids as well as on the levels of beta-oxidation of 3 suspected substrates: C26:0, C24:0, and C22:6n-3 (DHA). We found an inverse correlation between the fatty acid content of saturated (C26:0, C24:0) and monounsaturated (C26:1, C24:1) VLCFA and the expression level of ALDRP. Interestingly, we obtained a transdominant-negative effect of the inactive ALDRP-EGFP on ALDP function. This effect is due to a physical interaction between ALDRP and ALDP that we evidenced by proximity ligation assays and coimmunoprecipitation. Finally, the beta-oxidation assays demonstrate a role of ALDRP in the metabolism of saturated VLCFA (redundant with that of ALDP) but also a specific involvement of ALDRP in the metabolism of DHA.
Comments [show]
None has been submitted yet.
No. Sentence Comment
41 WT (clone 28) and D207H (clone 19) ALDRP-EGFP Tet-on cell clones were established as described previously (20), and cultured in the presence of 200 g/ml of G418 (InvivoGen) and 200 g/ml of hygromycin B (InvivoGen).
X
ABCD2 p.Asp207His 21209459:41:18
status: NEW46 To further select subclones expressing the highest expression levels of WT or D207H Abcd2-EGFP, cells were incubated or not for 24 h with 2 g/ml of doxycycline (Clontech).
X
ABCD2 p.Asp207His 21209459:46:78
status: NEW83 Coimmunoprecipitation Assays and Western Blotting- H4IIEC3 cells stably expressing D207H-ALDRP-EGFP after overnight induction with 2 g/ml of doxycycline or not were homogenized in solubilization buffer (100 mM Tris-HCl, pH 8, 100 mM NaCl, 10 mM EDTA, 1% Triton X-100, 1% PMSF and protease inhibitor mixtures (Roche Applied Science)).
X
ABCD2 p.Asp207His 21209459:83:83
status: NEW100 The mutant ALDRP-EGFP corresponds to a single change of the amino acid sequence (D207H) mimicking a natural mutation occurring in the ABCD1 gene (D196H ALDP), which results in a non-functional protein still able to dimerize and to be targeted at the peroxisomal membrane (25).
X
ABCD2 p.Asp207His 21209459:100:81
status: NEW109 Moreover, because the alteration of ALDRP (WT or D207H) expression was unlikely to result in strong modifications in normal conditions (ALDP and PMP70 are quite well expressed in H4IIEC3 cells), we challenged the cells with C26:0, the supposed preferential substrate of ALDP, and compared the different situations.
X
ABCD2 p.Asp207His 21209459:109:49
status: NEW120 Transdominant Negative Effect of D207H-ALDRP-EGFP- Parallel experiments were conducted with cell clone 19 expressing the mutant non-functional D207H-ALDRP-EGFP protein.
X
ABCD2 p.Asp207His 21209459:120:33
status: NEWX
ABCD2 p.Asp207His 21209459:120:143
status: NEW122 However, whereas induction of ALDRP-EGFP in clone 28 resulted in a decreased content of C26:0 and C24:0, doxycycline-dependent induction of D207H-ALDRP-EGFP resulted in a dose-dependent increase of the level of C26:0 (Fig. 2).
X
ABCD2 p.Asp207His 21209459:122:140
status: NEWX
ABCD2 p.Asp207His 21209459:122:165
status: NEW123 Because the basal level of expression of the endogenous ALDRP in cell clones is quasi null, this result may be the consequence of a transdominant-negative effect of D207H-ALDRP-EGFP on ALDP function.
X
ABCD2 p.Asp207His 21209459:123:0
status: NEWX
ABCD2 p.Asp207His 21209459:123:73
status: NEWX
ABCD2 p.Asp207His 21209459:123:165
status: NEW124 D207H-ALDRP-EGFP Interacts with ALDP-To evidence the interaction between D207H-ALDRP-EGFP and ALDP, we used two complementary approaches.
X
ABCD2 p.Asp207His 21209459:124:0
status: NEWX
ABCD2 p.Asp207His 21209459:124:73
status: NEWX
ABCD2 p.Asp207His 21209459:124:92
status: NEW125 First, we used a proximity ligation assay (PLA duolink) to analyze in situ the proximity of D207H-ALDRP-EGFP with ALDP.
X
ABCD2 p.Asp207His 21209459:125:92
status: NEW132 PLA experiments resulted in a positive labeling only in the presence of doxycycline and with the couple of antibodies directed against ALDP and GFP (Fig. 3B) demonstrating the proximity between ALDP and D207H- ALDRP-EGFP.
X
ABCD2 p.Asp207His 21209459:132:132
status: NEWX
ABCD2 p.Asp207His 21209459:132:203
status: NEW133 This labeling does not result from the overabundance of proteins in a membrane context because no PLA labeling was obtained between D207H-ALDRP-EGFP and proteins PEX14 or PMP22, PMP22 being the most represented protein of the peroxisomal membrane (28).
X
ABCD2 p.Asp207His 21209459:133:34
status: NEWX
ABCD2 p.Asp207His 21209459:133:132
status: NEW134 To confirm that proximity between D207H-ALDRP-EGFP and ALDP is due to a physical interaction, cross-coimmunoprecipitation experiments were carried out from cell lysates obtained from clone 19 cultivated in the presence of doxycycline.
X
ABCD2 p.Asp207His 21209459:134:21
status: NEWX
ABCD2 p.Asp207His 21209459:134:34
status: NEW135 As shown in Fig. 4A, D207H-ALDRP-EGFP was coimmunoprecipitated with ALDP by anti-ALDP antibody only in the doxycycline-treated cell clone 19.
X
ABCD2 p.Asp207His 21209459:135:21
status: NEWX
ABCD2 p.Asp207His 21209459:135:60
status: NEW136 In the cross-experiment, ALDP was coimmunoprecipitated with D207H-ALDRP-EGFP by anti-GFP antibody only in doxycycline-treated cell clone 19 (Fig. 4B) demonstrating interaction.
X
ABCD2 p.Asp207His 21209459:136:60
status: NEW138 Doxycycline-dependent expression of the WT or D207H Abcd2-EGFP gene in stable transfectant cell clones 28 and 19, respectively.
X
ABCD2 p.Asp207His 21209459:138:46
status: NEW143 Although we did not notice any change in the PUFA content nor in the n-7 monounsaturated fatty acid content whatever the conditions and the cell clones, the n-9 monounsaturated fatty acid content demonstrated alteration depending on the expression level of WT or D207H-ALDRP-EGFP protein (Fig. 5).3 F. Geillon, D. Trompier, C. Gondcaille, and S. Savary, manuscript in preparation.
X
ABCD2 p.Asp207His 21209459:143:263
status: NEW145 GC-MS analysis of the saturated fatty acid content in phospholipids of cell clones 28 (WT ALDRP-EGFP) and 19 (D207H-ALDRP-EGFP) cultivated in the presence of various doses of doxycycline and in the absence or presence of C26:0.
X
ABCD2 p.Asp207His 21209459:145:110
status: NEW150 On the contrary, doxycycline-dependent induction of D207H-ALDRP-EGFP resulted in a dose-dependent increase of the level of C26:1n-9, although non-statistically significant.
X
ABCD2 p.Asp207His 21209459:150:52
status: NEW161 However, the increased level of beta-oxidation of DHA was unexpected because the levels of PUFA in PL appeared to be insensitive to the level of expression of ALDRP- FIGURE3.InsituanalysisoftheproximityofALDRP-EGFPwithotherperoxisomalproteins.A,immunofluorescencedetection(IFsignal)ofD207H-ALDRP-EGFP, ALDP, PEX14, and PMP22 observed by confocal microscopy in clone 19 (D207H-ALDRP-EGFP) induced by doxycycline (DOX) (2 g/ml for 48 h).
X
ABCD2 p.Asp207His 21209459:161:370
status: NEW162 B, Duolink proximity ligation assay between D207H-ALDRP-EGFP and ALDP, PEX14, and PMP22 in clone 19 induced by doxycycline observed by confocal microscopy.
X
ABCD2 p.Asp207His 21209459:162:44
status: NEW164 Coimmunoprecipitation of ALDP and D207H-ALDRP-EGFP demonstrating interaction.
X
ABCD2 p.Asp207His 21209459:164:34
status: NEW165 Cell lysates from cell clone 19 (D207H-ALDRP-EGFP) treated or not with doxycycline (dox) (2 g/ml) for 18 h were used for anti-ALDP(A)oranti-GFP(B)immunoprecipitation.Aliquotsofcelllysatesand eluted fractions were separated on 7.5% SDS gels, blotted, and probed with anti-ALDP or anti-GFP antibodies. Substrate Specificity of ALDRP 8080 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 286•NUMBER 10•MARCH 11, EGFP.
X
ABCD2 p.Asp207His 21209459:165:33
status: NEW166 Induction of D207H-ALDRP-EGFP resulted in a weak but significant decrease of the beta-oxidation level of C26:0.
X
ABCD2 p.Asp207His 21209459:166:13
status: NEW172 GC-MS analysis of the n-9 monounsaturated fatty acid content in phospholipids of cell clones 28 (WT ALDRP-EGFP) and 19 (D207H-ALDRP-EGFP) cultivated in the presence of various doses of doxycycline and in the absence or presence of C26:0.
X
ABCD2 p.Asp207His 21209459:172:120
status: NEW176 On the contrary, induction of the D207H-ALDRP-EGFP protein was expected not to modify the fatty acid content of PL and serve as a control.
X
ABCD2 p.Asp207His 21209459:176:34
status: NEW201 The direct correlation between the level of C26:0 and C26:1 in PL and the expression level of the D207H-ALDRP-EGFP fusion protein demonstrated a transdominant-negative effect of the mutant protein.
X
ABCD2 p.Asp207His 21209459:201:98
status: NEW202 This effect was also found in beta-oxidation assays as a decreased beta-oxidation activity of C26:0 was observed upon induction of D207H-ALDRP-EGFP.
X
ABCD2 p.Asp207His 21209459:202:131
status: NEW203 Duolink and coimmunoprecipitation experiments have evidenced interactions between D207H-ALDRP-EGFP and ALDP.
X
ABCD2 p.Asp207His 21209459:203:82
status: NEW204 The formation of a non-functional heterodimer D207H-ALDRP-EGFP/ALDP would deprive the cell of functional ALDP/ALDP homodimers and then result in the accumulation of C26:0 and C26:1 mimicking a deficiency on ALDP.
X
ABCD2 p.Asp207His 21209459:204:46
status: NEW206 beta-Oxidation levels of 14 C-C26:0 (A), C24:0 (B), and C22:6n-3 (C) in clones 28.38 (WT ALDRP-EGFP) and 19.55 (D207H-ALDRP-EGFP) cultivated in the absence or presence of doxycycline (2 g/ml).
X
ABCD2 p.Asp207His 21209459:206:112
status: NEW211 Altogether, we can conclude that D207H-ALDRP-EGFP has a transdominant-negative effect on ALDP function.
X
ABCD2 p.Asp207His 21209459:211:33
status: NEW40 WT (clone 28) and D207H (clone 19) ALDRP-EGFP Tet-on cell clones were established as described previously (20), and cultured in the presence of 200 òe;g/ml of G418 (InvivoGen) and 200 òe;g/ml of hygromycin B (InvivoGen).
X
ABCD2 p.Asp207His 21209459:40:18
status: NEW45 To further select subclones expressing the highest expression levels of WT or D207H Abcd2-EGFP, cells were incubated or not for 24 h with 2 òe;g/ml of doxycycline (Clontech).
X
ABCD2 p.Asp207His 21209459:45:78
status: NEW82 Coimmunoprecipitation Assays and Western Blotting- H4IIEC3 cells stably expressing D207H-ALDRP-EGFP after overnight induction with 2 òe;g/ml of doxycycline or not were homogenized in solubilization buffer (100 mM Tris-HCl, pH 8, 100 mM NaCl, 10 mM EDTA, 1% Triton X-100, 1% PMSF and protease inhibitor mixtures (Roche Applied Science)).
X
ABCD2 p.Asp207His 21209459:82:83
status: NEW99 The mutant ALDRP-EGFP corresponds to a single change of the amino acid sequence (D207H) mimicking a natural mutation occurring in the ABCD1 gene (D196H ALDP), which results in a non-functional protein still able to dimerize and to be targeted at the peroxisomal membrane (25).
X
ABCD2 p.Asp207His 21209459:99:81
status: NEW108 Moreover, because the alteration of ALDRP (WT or D207H) expression was unlikely to result in strong modifications in normal conditions (ALDP and PMP70 are quite well expressed in H4IIEC3 cells), we challenged the cells with C26:0, the supposed preferential substrate of ALDP, and compared the different situations.
X
ABCD2 p.Asp207His 21209459:108:49
status: NEW119 Transdominant Negative Effect of D207H-ALDRP-EGFP- Parallel experiments were conducted with cell clone 19 expressing the mutant non-functional D207H-ALDRP-EGFP protein.
X
ABCD2 p.Asp207His 21209459:119:33
status: NEWX
ABCD2 p.Asp207His 21209459:119:143
status: NEW121 However, whereas induction of ALDRP-EGFP in clone 28 resulted in a decreased content of C26:0 and C24:0, doxycycline-dependent induction of D207H-ALDRP-EGFP resulted in a dose-dependent increase of the level of C26:0 (Fig. 2).
X
ABCD2 p.Asp207His 21209459:121:140
status: NEW131 PLA experiments resulted in a positive labeling only in the presence of doxycycline and with the couple of antibodies directed against ALDP and GFP (Fig. 3B) demonstrating the proximity between ALDP and D207H- ALDRP-EGFP.
X
ABCD2 p.Asp207His 21209459:131:203
status: NEW137 Doxycycline-dependent expression of the WT or D207H Abcd2-EGFP gene in stable transfectant cell clones 28 and 19, respectively.
X
ABCD2 p.Asp207His 21209459:137:46
status: NEW142 Although we did not notice any change in the PUFA content nor in the n-7 monounsaturated fatty acid content whatever the conditions and the cell clones, the n-9 monounsaturated fatty acid content demonstrated alteration depending on the expression level of WT or D207H-ALDRP-EGFP protein (Fig. 5).
X
ABCD2 p.Asp207His 21209459:142:263
status: NEW[hide] A novel cell model to study the function of the ad... Biochem Biophys Res Commun. 2006 Mar 3;341(1):150-7. Epub 2006 Jan 6. Gueugnon F, Volodina N, Taouil JE, Lopez TE, Gondcaille C, Grand AS, Mooijer PA, Kemp S, Wanders RJ, Savary S
A novel cell model to study the function of the adrenoleukodystrophy-related protein.
Biochem Biophys Res Commun. 2006 Mar 3;341(1):150-7. Epub 2006 Jan 6., [PMID:16412981]
Abstract [show]
X-linked adrenoleukodystrophy (X-ALD) is a neurodegenerative disorder due to mutations in the ABCD1 (ALD) gene. ALDRP, the closest homolog of ALDP, has been shown to have partial functional redundancy with ALDP and, when overexpressed, can compensate for the loss-of-function of ALDP. In order to characterize the function of ALDRP and to understand the phenomenon of gene redundancy, we have developed a novel system that allows the controlled expression of the ALDRP-EGFP fusion protein (normal or non-functional mutated ALDRP) using the Tet-On system in H4IIEC3 rat hepatoma cells. The generated stable cell lines express negligible levels of endogenous ALDRP and doxycycline dosage-dependent levels of normal or mutated ALDRP. Importantly, the ALDRP-EGFP protein is targeted correctly to peroxisome and is functional. The obtained cell lines will be an indispensable tool in our further studies aimed at the resolution of the function of ALDRP to characterize its potential substrates in a natural context.
Comments [show]
None has been submitted yet.
No. Sentence Comment
42 Site directed mutagenesis was performed on the ALDRP-EGFP-pTRE2hyg to obtain the mutated construct D207H-ALDRP-EGFP-pTRE2hyg (GAC codon 619 switched to CAC).
X
ABCD2 p.Asp207His 16412981:42:99
status: NEW86 One microgram of the ALDRP, ALDRP-EGFP, or D207H- ALDRP-EGFP pcDNA3.1/Zeo(+) constructs was used as template in a final volume of 50 ll.
X
ABCD2 p.Asp207His 16412981:86:43
status: NEW149 or with D207H-ALDRP-EGFP-pTRE2hyg.
X
ABCD2 p.Asp207His 16412981:149:8
status: NEW162 Taken together, the results indicate that the clones 28 and 19 express ALDRP-EGFP and D207H-ALDRP-EGFP, respectively, at a high level in the peroxisome upon doxycycline treatment.
X
ABCD2 p.Asp207His 16412981:162:86
status: NEW165 Maximum level of induction (9-fold for the ALDRP-EGFP mRNA and 15-fold for D207H-ALDRP-EGFP mRNA) was reached with 2 lg/ml doxycycline.
X
ABCD2 p.Asp207His 16412981:165:75
status: NEW170 Analysis of the expression and of the subcellular localization of the normal and mutated (D207H) ALDRP-EGFP.
X
ABCD2 p.Asp207His 16412981:170:90
status: NEW171 (A) In vitro translation of the ALDRP, ALDRP-EGFP, or D207H-ALDRP-EGFP pcDNA3.1/Zeo(+) constructs using L[35 S]methionine.
X
ABCD2 p.Asp207His 16412981:171:54
status: NEW187 Characterization of the H4IIEC3-TetOn cell clones expressing a normal (clone 28) or mutated (D207H, clone 19) ALDRP-EGFP fusion protein upon doxycycline treatment.
X
ABCD2 p.Asp207His 16412981:187:93
status: NEW199 Quantification of the relative expression levels of mRNA of the fusion proteins by quantitative real-time RT-PCR with primers against Abcd2 in the H4IIEC3-TetOn cell clones expressing normal ALDRP-EGFP protein-clone 28 (open rectangles) and mutated (D207H) ALDRP-EGFP protein-clone 19 (filled rectangles).
X
ABCD2 p.Asp207His 16412981:199:250
status: NEW214 The D207H mutation in ALDRP is similar to the D194H mutation in ALDP that has been previously studied by stable transfection and has been shown to disrupt function without suppressing the capacity of dimerization and of import in the peroxisomal membrane [30].
X
ABCD2 p.Asp207His 16412981:214:4
status: NEW